Stockwinners Market Radar for March 14, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:44 EDT Target exec sells $5.56M in common stock - In a regulatory filing, Target disclosed that its Executive Officer Brian Cornell sold 35K shares of common stock on March 14th in a total transaction size of $5.56M.

20:12 EDT Accelerate Diagnostics CFO Steve Reichling to step down - On March 9, 2023, Steve Reichling "notified Accelerate Diagnostics of his decision to resign as CFO of the Company, effective March 31, 2023. Mr. Reichling currently serves as the Company's principal financial officer and principal accounting officer. Mr. Reichling's resignation is for personal reasons and is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. In connection with Mr. Reichling's resignation, on March 9, 2023, the Company and Mr. Reichling entered into a consulting services agreement, pursuant to which Mr. Reichling has agreed to provide certain consulting and transitional services to the Company beginning April 3, 2023 through December 29, 2023, unless earlier terminated in accordance with the Reichling Consulting Agreement. In consideration of the services to be provided by Mr. Reichling, the Company will grant him 275,248 shares of the Company's common stock on or about April 3, 2023, with 50% of such shares vesting immediately upon grant, 25% vesting on or about August 13, 2023 and the remaining 25% vesting on or about December 13, 2023. Mr. Reichling has also agreed to certain covenants regarding non-solicitation, confidentiality and intellectual property rights."

20:06 EDT Cathie Wood's ARK Investment bought 23.3K shares of Pinterest today

20:05 EDT Cathie Wood's ARK Investment bought 130.5K shares of Cerus today

20:00 EDT Global Water Resources' former director buys $7.3M in common stock - In a regulatory filing, Global Water Resources disclosed that its former director William Levine bought 541K shares of common stock in a total transaction size of $7.3M. Shares of Global Water Resources are up 4.8% in afterhours trading.

19:36 EDT Vector Group director sells $1.42M in common stock - In a regulatory filing, Vector Group disclosed that its director Bennett Lebow sold 117.5K shares of common stock on March 10th in a total transaction size of $1.24M.

19:16 EDT Ashford Hospitality says 42% of cash held in short-term Treasuries - Ashford Hospitality Trust issued the following statement today: In light of recent events in the banking industry, the Company thought it would be helpful to provide some clarity on its current cash holdings. Currently, approximately 42% of the Company's cash is held in short-term U.S. Treasury Securities with maturity dates of less than 90 days. Approximately 27% is held at commercial banks in Insured Cash Sweep accounts, which are fully insured by the FDIC. Approximately 30% relates to property-level operating cash deposited with commercial banks that have been designated as a Global Systemically Important Bank by the Financial Stability Board.

18:29 EDT Harpoon Therapeutics announces acceptance of five abstracts for AACR meeting - Harpoon Therapeutics "announced that it will present data from five preclinical investigations in poster presentations at the American Association for Cancer Research, or AACR, Annual Meeting being held in Orlando, Fla., April 14-19, 2023." CEO Julie Eastland states: "The breadth of data from Harpoon's five poster presentations at AACR supports further investigation of additional tumor targets, combination approaches with TriTACs(R), as well as our next-generation technology platform with conditionally active T cell engager prodrugs, or ProTriTACs(TM). Additionally, the preclinical data investigating the activity of TriTAC in an immunocompetent mouse model provide further validation of our ongoing and planned clinical efforts with HPN328 and HPN217, leveraging our proprietary TriTAC T cell engager platform. We look forward to further validation in the clinic as our research efforts continue."

18:24 EDT Carl Icahn increases stake in Southwest Gas by $32M - In a regulatory filing, Carl Icahn disclosed that he purchased an additional 539K shares of common stock on March 10th in a total transaction size of $32.0M. The increased holding comes in addition to Friday's purchase of 2.33M shares for $140M.

18:08 EDT Moderna announces two presentations on mRNA-4157/V940 at AACR - Moderna announced that two abstracts on mRNA-4157/V940 an investigational mRNA personalized cancer vaccine, have been accepted for presentation at the 2023 American Association of Cancer Research, or AACR, Annual Meeting being held April 14-19 in Orlando, FL. mRNA-4157/V940 is being jointly developed by Moderna and Merck, known as MSD outside of the United States and Canada. The two abstract titles are: A personalized cancer vaccine, mRNA-4157, combined with pembrolizumab versus pembrolizumab in patients with resected high-risk melanoma: Efficacy and safety results from the randomized, open- label Phase 2 mRNA-4157-P201/Keynote-942 trial. Harnessing the Immune System in the Clinic; and Evaluation of minimal residual disease as a predictive biomarker of recurrence free survival in high-risk melanoma patients treated with a combination of mRNA-4157, a personalized cancer vaccine, and pembrolizumab. AACR will post the text of late-breaking and clinical trials abstracts in the AACR Annual Meeting online itinerary planner and Annual Meeting app on April 14.

17:58 EDT Comscore director buys $255K in common stock - In a regulatory filing, Comscore disclosed that its director William Livek bought 250K shares of common stock on March 13th in a total transaction size of $255K.

17:40 EDT Four Corners Property Trust announce acquisition of an Aspen Dental property - Four Corners Property Trust announced the acquisition of an Aspen Dental property for $1.9M. The property is located in a strong retail corridor in New Mexico and is corporate-operated. The transaction was priced at a cap rate in range with previous FCPT transactions.

17:18 EDT Eversource COO to retire July 1 - Eversource Energ announced that Werner J. Schweiger, the company's Executive Vice President and Chief Operating Officer, advised the Company of his intention to retire effective July 1, 2023. Mr. Schweiger will resign as Executive Vice President and Chief Operating Officer on a date mutually agreeable to Mr. Schweiger and the Company prior to July 1, 2023. Effective upon Mr. Schweiger's resignation, James W. Hunt, III, the Company's Executive Vice President-Corporate Relations and Sustainability and Secretary, will serve as Chief Operating Officer on an interim basis. Mr. Schweiger will continue to serve the Company as a strategic advisor to Mr. Hunt and the Company until his retirement date.

17:09 EDT General Dynamics awarded $1.48B Army contract modification - General was awarded a $1.48B modification to a contract to manufacture large-caliber metal projectiles and mortar projectiles. Work locations and funding will be determined with each order, with an estimated completion date of July 30, 2029. U.S. Army Contracting Command is the contracting activity.

17:02 EDT Ancora 'very pleased' IAA, Ritchie Bros. shareholders approve revised deal - Ancora Holdings, which is the beneficial owner of approximately 4% of the outstanding shares of IAA, Inc. (IAA) and 0.5% of the outstanding shares of Ritchie Bros. Auctioneers Incorporated (RBA), applauded the approval of the companies' combination. Fredrick D. DiSanto, Chairman and Chief Executive Officer of Ancora, and James Chadwick, President of Ancora Alternatives LLC, commented: "We are very pleased that IAA shareholders and Ritchie Bros. shareholders have approved the revised transaction, which stands to create a dominant player in the industry and a source of long-term value creation. We look forward to supporting Ann Fandozzi and her talented management team as they work to integrate both companies in the coming months. Ann is an exceptional leader that has our full confidence. We also believe our director designee, Tim O'Day, will add significant expertise to the combined entity's new Board of Directors."

17:00 EDT Bellicum Pharmaceuticals trading resumes

16:52 EDT SEC charges DXC Technology with making misleading disclosures - The Securities and Exchange Commission charged DXC Technology Company, an IT services company in Ashburn, Virginia, with making misleading disclosures about its non-GAAP financial performance in multiple reporting periods from 2018 until early 2020. According to the SEC's order, DXC materially increased its reported non-GAAP net income by negligently misclassifying tens of millions of dollars of expenses as non-GAAP adjustments for so-called transaction, separation, and integration-related (TSI) costs and improperly excluding them from its non-GAAP earnings. While DXC publicly claimed that its non-GAAP metrics allowed investors "to better understand the financial performance of DXC," the SEC's order finds that the company's non-GAAP disclosure controls and procedures were inadequate to ensure that the company's expense classifications were consistent with its own public description of TSI costs. According to the order, by misclassifying TSI costs, DXC materially overstated its non-GAAP net income in three fiscal quarters. DXC also failed to evaluate the company's non-GAAP disclosures concerning TSI costs. The Commission's order finds that DXC negligently violated the anti-fraud provisions of the Securities Act of 1933 and reporting provisions of the federal securities laws. Without admitting or denying the findings in the order, DXC consented to a cease-and-desist order, to pay an $8 million penalty, and to undertake to develop and implement appropriate non-GAAP policies and disclosure controls and procedures. In determining to accept DXC's offer of settlement, the SEC considered DXC's cooperation and remedial actions.

16:36 EDT Lennar sees Q2 new orders 16,000-17,000 - Sees Q2 deliveries 15,000-16,000; average sales price $435,000-$445,000; Gross Margin % on Home Sales 21.0%-21.5%; S,G&A as a % of Home Sales 7.2%-7.4%; and financial services operating earnings $70M-$75M. Stuart Miller, Executive Chairman of Lennar, said,"As we have seen over the past quarters, interest rates are fluctuating and are likely to continue to move, and the housing market will continue to rebalance pricing and interest rates. While we have a clear-cut strategy of execution, we will only give broad boundaries for deliveries and gross margin. For the Q2, the range for deliveries will be between 15,000 to 16,000 homes and gross margin will be 21.0% to 21.5%. For the FY23, the range for deliveries will be between 62,000 to 66,000 homes. We continue to fortify our balance sheet with significant liquidity and operate from a position of strength, enabling us to continue to execute on our core strategies and outperform in periods of uncertainty."

16:32 EDT Bellicum Pharmaceuticals to discontinue GoCAR-T trials, evaluate alternatives - Bellicum Pharmaceuticals announced its decision to discontinue its ongoing Phase 1/2 clinical trials evaluating the safety and preliminary efficacy of its GoCAR-T cell product candidates in combination with rimiducid in heavily pre-treated cancer patients. The trials for BPX-601 and BPX-603 are being discontinued following the company's assessment of the risk/benefit profile of BPX-601 in combination with rimiducid. The most recent patient treated in the Phase 1/2 trial of BPX-601 in metastatic castration-resistant prostate cancer, or mCRPC, experienced serious immune-mediated adverse events including Grade 4 cytokine release syndrome, or CRS, the second dose-limiting toxicity observed in this cohort of dose escalation. The company paused enrollment in its clinical studies and conducted a thorough review of the risk/benefit observed to date. While clinically meaningful efficacy has been observed-including 5 of 9 mCRPC patients treated achieving PSA50 response, 4 of whom achieved PSA90 response-the Company believes it does not have the necessary resources to optimize either the clinical dose and schedule of BPX-601 cells and the activating agent rimiducid, or the design of the BPX-601 cell construct to achieve a favorable risk/benefit profile. The company is communicating with clinical trial sites and regulatory agencies regarding its decision to discontinue its trials, and an evaluation of the company's strategic alternatives is underway.

16:29 EDT Atlas Air expects to consummate Apollo merger on or about March 17 - In a regulatory filing, Atlas Air (AAWW) stated: As previously disclosed, on August 4, 2022, Atlas Air Worldwide Holdings entered into an Agreement and Plan of Merger with Rand Parent, LLC, a Delaware limited liability company affiliated with certain funds managed by affiliates of Apollo Global Management, Inc., J.F. Lehman & Company, LLC and Hill City Capital LP, and Rand Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent, which provides for the merger of MergerCo with and into the Company with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. As of March 14, 2023, all regulatory conditions to closing set forth in the Merger Agreement were satisfied. Subject to the satisfaction or waiver of the remaining closing conditions, the Company expects to consummate the Merger on or about March 17, 2023."

16:25 EDT Bellicum Pharmaceuticals trading halted, news pending

16:20 EDT Laird Superfood sees FY23 revenue growth in high single digits, consensus $39.9M - The company said, "We anticipate that uncertain economic environment with historically high inflation rates impacting consumer spending will continue into 2023. We believe that strategic actions we have taken in 2022, and continue to take in 2023, have positioned the business for net sales growth in the high single digits and gross margin in excess of 30%, excluding extraordinary events. Gross margin guidance excludes any one-time charges associated with the any non-recurring actions."

16:16 EDT Arcosa awarded $750M in additional tower ordes - Arcosa announced that it has received wind tower orders of approximately $750M for delivery beginning in 2024 and continuing through 2028. The majority of these orders will support wind energy expansion projects currently underway in the Southwest. As a result, Arcosa plans to open a manufacturing facility in Belen, New Mexico, strategically located to supply these major projects.

16:14 EDT Safe Bulkers sells Panamax classdry-bulk vessel at a gross sale price of $22.5M - Safe Bulkers announced that it has entered into an agreement for the sale of a Kamsarmax MV Efrossini, a 2012 Japanese-built, Panamax class, dry-bulk vessel at a gross sale price of $22.5M and forward delivery date within June 2023. Upon delivery to new owners, the vessel will be chartered back by the Company at a gross daily charter rate of $16,050 for a period of ten to fourteen months.Dr. Loukas Barmparis, President of the Company commented: "Having ordered recently an additional IMO Phase 3 newbuild Kamsarmax vessel and sold a 2012 Panamax vessel, we continue our strategy to selectively sale relatively older tonnage and gradually replace it with newbuilds of latest available designs, aiming to improve our fleets' environmental performance and increase our competitiveness in a new more stringent regulatory environment.''

16:13 EDT Broadstone Net Lease launches $150M buyback program - Broadstone Net Lease announced that its Board of Directors has authorized the repurchase of up to $150 million of its outstanding common stock under a stock repurchase program. The authorization will expire on March 14, 2024.

16:08 EDT Beachbody reports Q4 total subscriptions at 2.17M, down 23.6% from last year - Reports Q4 DAUs and MAUs up 10% from last year.

16:07 EDT Smartsheet names Mike Gregoire board chair - Smartsheet announced that the Executive Committee of its Board of Directors has appointed Smartsheet director Mike Gregoire as board chair. Effective March 9, 2023, Gregoire succeeds Geoffrey Barker, who has served as board chair since 2017 and will remain a member of the board. "I feel privileged to take on this expanded leadership role on Smartsheet's board. Smartsheet is cementing its global leadership in the collaborative work management space, and I look forward to working with the company and the board to grow Smartsheet's enterprise investments for durable, long-term growth," said Gregoire. "Mike has been a valuable member of the Smartsheet board since late 2019," said Mark Mader, Smartsheet CEO. "His expertise in operating technology companies at scale aligns very well with our next phase of growth. In sharing experiences ranging from distribution and corporate development to customer enablement and governance, Mike has helped us develop better strategies and stronger outcomes for Smartsheet stakeholders. I look forward to working even more closely with Mike as our new board chair."

16:03 EDT Fluor sells AMECO South American to STRACON - Fluor Corporation announced that the company sold its AMECO South America business, which includes assets in Chile and Peru, to STRACON Group, a diversified strategic partner to the mining sector in the Americas. This transaction marks the completion of the AMECO divestiture which was a strategic initiative to allow Fluor to focus on its core businesses and capital priorities. Previous AMECO divestitures included company assets in Africa, the Caribbean, Mexico and North America.

15:43 EDT Western Alliance down 6% in late day trading - Shares of Western Alliance Bancorporation, which were up by over 52% earlier in today's session, are down $1.52, or 6%, to $24.60 in late day trading.

15:30 EDT Supermicro expands storage solutions line with all-flash NVMe server family - Supermicro is announcing the latest addition to its revolutionary ultra-high performance, high-density petascale class all-flash NVMe server family. Supermicro systems in this high-performance storage product family will support the next-generation EDSFF form factor, including the E3.S and E1.S devices, in form factors that accommodate 16- and 32 high-performance PCIe Gen5 NVMe drive bays. The initial offering of the updated product line will support up to one-half of a petabyte of storage space in a 1U 16 bay rackmount system, followed by a full petabyte of storage space in a 2U 32 bay rackmount system for both Intel and AMD PCIe Gen5 platforms. All of the Supermicro systems that support either the E1.S or E3.s form factors enable customers to realize the benefits in various application-optimized servers. "Supermicro continues to address our users' requirements with innovative solutions for today's and tomorrow's workloads," said Charles Liang, president and CEO of Supermicro. "With up to a petabyte of storage in a standard rackmount system, users can quickly access tremendous amounts of data at their fingertips. The new storage system is compact and energy efficient and will give our users the lowest latency and highest bandwidth in the industry. The performance and capacity of these new systems enable customers to gain insight using advanced AI technologies. Using our building block architecture, we can bring the latest technologies to market faster, giving users advanced systems as part of our Total IT Solutions rack scale offerings."

15:03 EDT BayCom says capital and liquidity positions 'remain strong' - BayCom Corp and its wholly owned subsidiary United Business Bank, a Western Regional bank, confirmed its capital and liquidity positions "remain strong." The company said: "The Bank has access to approximately $1.1 billion in liquidity from numerous sources including its borrowing capacity at Federal Home Loan Bank. In addition, the Bank is eligible to receive funds under the new Bank Term Funding Program announced by the Federal Reserve today." Founder and President, George Guarini added: "The cornerstone of the United Business Bank's business model is diversification: diversification of the markets we serve, diversification of the loan products we offer, diversification in our investment portfolio, diversification of the client profiles we bank and diversification of our revenue sources. BayCom employs a community bank strategy by way of gathering in-market deposits and lending to local clients and businesses in a conservative manner. Our total deposits have increased since year end, and our more recent deposit activities appear to be within the normal course of business. The Bank's capital remains well above the regulatory threshold for well-capitalized banks, and its liquidity position remains strong. The Bank continues to process transactions and loan fundings to fully serve the needs of our clients."

14:39 EDT Morgan Stanley Wealth Management announces key milestone with OpenAI - Morgan Stanley Wealth Management announced an important milestone in its innovation journey through the launch of a strategic initiative to create a bespoke solution with OpenAI, the artificial intelligence research and deployment lab. The business unit is one of a handful of GPT-4 launch organizations, and Morgan Stanley is currently the only strategic client in wealth management receiving early access to OpenAI's new products. MSWM will leverage OpenAI's technology to access, process and synthesize content to assimilate MSWM's own expansive range of intellectual capital in the form of insights into companies, sectors, asset classes, capital markets, and regions around the world. Designed specifically for and by Morgan Stanley with appropriate controls, Financial Advisors and their teams will use the internal capability to ask questions and contemplate large amounts of content and data, with answers delivered in an easily digestible format generated exclusively from MSWM content and with links to the source documents. The stream of interactions and feedback from these queries will help further refine the offering while helping Financial Advisors to better serve their clients. The announcement comes on the heels of recent MSWM AI projects that include Next Best Action, an internally-built AI-based engine that delivers timely, customized messages to clients and prospects guided by the Financial Advisor. MSWM has also been implementing its proprietary Genome capability through the self-directed and workplace channels, which uses data analytics and machine learning to further personalize client communication. Morgan Stanley Wealth Management is also considering additional OpenAI technology, which has the potential to enhance the insights from Financial Advisors' notes and streamline follow-up client communications.

13:36 EDT Charles Schwab CEO says bought 50,000 shares today for personal account - Charles Schwab CEO Walter Bettinger says he cannot comment on share repurchases made by the company, but that he personally bought stock this morning. Bettinger made the comments while being interviewed on CNBC.

13:32 EDT CEO says AMC 'APE' conversion approved by shareholders - AMC Entertainment's shareholders voted in favor of increasing the company's stock authorization and converting AMC Preferred Equity Units into AMC common shares. AMC's CEO Adam Aron said in a series of tweets that, "Today was a huge step forward for AMC. You voted YES, YES & YES! And it was a landslide vote too - 88% yes for Proposal 1, 87% yes for Proposal 2, and 87% yes for Proposal 3. My sincerest thanks for giving AMC the tools we need to continue fighting the good fight on your behalf. Saving AMC is my professional mission. And remember that I own millions of AMC shares and APE units too. So, I very much want for AMC to succeed. I am absolutely and passionately convinced that what you approved today is in the best interests of AMC and of all our shareholders. So what happens now? We cannot implement what you approved today until the litigation in Delaware courts is resolved. The next Court hearing on this matter is set for April 27, 2023. We will update stockholders when we have additional information." Shares of AMC have dropped over 16% to $4.58 in Tuesday trading. Reference Link

13:10 EDT Macy's launches expanded Reebok assortment in stores, online - Macy's (M) is expanding its partnership with Reebok (AUTH), saying the collection includes sportswear and activewear for men and women, including extended sizes that span fitness, lifestyle, and various training categories. In addition to the expanded assortment, Reebok will also develop products and capsule collections exclusively for Macy's. "Starting today, customers can shop the sportswear assortment, which includes shirts, jackets, joggers, leggings, sports bras, accessories, and more at prices ranging from $25 to $85 on macys.com, the Macy's mobile app and at select Macy's stores nationwide," Macy's said. "We are thrilled to expand our partnership with Reebok, a brand with a very rich heritage that is having a big moment," said Rachel Leinwand, Macy's vice president of merchandising Active, Basics, Outdoor. "We are collaborating with Reebok in the design process to bring exclusive products to our customers. The partnership with Reebok expands our sportswear and activewear assortment in a space where Reebok has authority, giving our customers more ways to own their style."

12:58 EDT Sumitomo Pharma granted orphan status for Ewing sarcoma treatment - The FDA granted Sumitomo Pharma orphan status for its treatment of Ewing sarcoma. Reference Link

12:40 EDT Veru says terminating Phase 3 VERACITY trial of sabizabulin - In a regulatory filing, Veru stated that on March 14, at the Oppenheimer 33rd Annual Healthcare Conference, Dr. Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of the company, presented Veru's updated strategy as part of the company's ongoing effort to refocus its drug development efforts on those drug candidates which it believes have the best opportunity to lead to long-term success and shareholder value creation and conserve cash, including a reduction in personnel and certain other measures to reduce costs. "The presentation included a description of Veru's refocused research and development strategy which includes the following: (i) plans for continued development of sabizabulin in Phase 3 COVID-19 confirmatory study in hospitalized moderate to severe COVID-19 patients at high risk for acute respiratory disease syndrome, or 'ARDS,' and planned development of sabizabulin in Phase 3 clinical study in hospitalized influenza patients at high risk for ARDS, (ii) plans for an updated ongoing Phase 3 study of enobosarm and abemaciclib combination in the second line setting for AR+ ER+ HER2- metastatic breast cancer patients, into which Veru plans to roll the current ARTEST study, if agreed by the U.S. Food and Drug Administration and the company's clinical trial partner, Eli Lilly & Company (LLY), and (iii) a planned Phase 3 study of enobosarm in bone-only non-measurable metastatic ER+ HER2- breast cancer. In addition, Dr. Steiner announced that Veru is reserving sabizabulin for clinical development only in infectious disease indications, and accordingly, terminating the Phase 3 VERACITY trial of sabizabulin in certain prostate cancer patients. Further, Phase 2 development of the Veru-100 and zuclomiphene assets will be paused. On March 2, 2023, Veru had announced that the FDA declined to grant at this time Veru's request for Emergency Use Authorization for sabizabulin to treat hospitalized adult patients with moderate to severe COVID-19 who are at high risk for ARDS," the filing stated.

12:29 EDT IAA shareholders approve merger agreement with Ritchie Bros. - IAA (IAA) announced that its stockholders adopted the previously announced merger agreement providing for the stock and cash acquisition of the company by Ritchie Bros. Auctioneers (RBA) at a special meeting held earlier today. In a separate special meeting of shareholders held earlier today, based on a preliminary vote count, Ritchie Bros. shareholders also voted to approve all proposals necessary to consummate the transaction. Accordingly, all stockholder and regulatory approvals required to consummate the transaction have now been obtained. Under the terms of the merger agreement, IAA stockholders will receive $12.80 per share in cash and 0.5252 common shares of Ritchie Bros. for each share of IAA common stock they own. Upon completion of the transaction, the parties expect that on a fully diluted basis IAA stockholders will own approximately 37.2% of the combined company and Ritchie Bros. shareholders will own approximately 62.8%.

12:19 EDT AMC Entertainment trading resumes

12:14 EDT AMC Entertainment trading halted, volatility trading pause

12:00 EDT TAL Education falls -11.8% - TAL Education is down -11.8%, or -80c to $6.00.

12:00 EDT Western Alliance rises 39.5% - Western Alliance is up 39.5%, or $10.32 to $36.44.

12:00 EDT First Republic rises 49.1% - First Republic is up 49.1%, or $15.31 to $46.52.

11:35 EDT Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass - Rod Fergusson, general manager of the "Diablo" franchise at Activision Blizzard (ATVI), said that the studio has "no plans" to have upcoming title "Diablo IV" on Xbox Game Pass (MSFT). Reference Link

11:21 EDT Red Cat announces 'materially significant financial investment' in Firestorm - Red Cat Holdings announced it has made "a materially significant financial investment" in Firestorm, an American company that it says is developing "the first completely Modular Unmanned Aerial System, or MUAS, that is 3D printed and payload agnostic." "Firestorm is changing how UAV's can be designed, manufactured, and delivered quickly, and the Firestorm system solves a lot of problems for many critical situations. Their long-range and long-duration loitering capabilities are a cost-effective approach to winning in the air. We believe that our Teal 2 drone and the Firestorm UAV could be a great combination for the warfighter. We want to help Firestorm succeed, and this investment may be just the beginning. For example, our large manufacturing facility in Salt Lake City could accelerate the production of Firestorm's products to meet increased demand," said Red Cat CEO Jeff Thompson.

11:06 EDT Shyft Group launches service body operation in Lebanon, Tennessee - The Shyft Group announced a new service body operation in Lebanon, Tennessee, just east of Nashville. This new operation will serve truck dealers, distributors and fleet customers in surrounding states, including new chassis pools for expanded dealer sales and support. The new, purpose-built 70,000-square-foot facility will serve as a sales branch as well as operations for upfit, mounting, fabrication, undercoat and paint services to Shyft's service body and accessory brands including Royal(R) Truck Body, DuraMag, Magnum and police car upfit and light accessories from Strobes-R-Us.

10:24 EDT ViewRay sees no material impact to operations from SVB's closure, receivership - In a regulatory filing, ViewRay stated: "As disclosed in ViewRay's Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission on February 28, 2023, the company has held a significant majority of its cash, cash equivalents, and short-term investments with Silicon Valley Bank (SIVB). Beginning Monday, March 13, 2023, the company moved the majority of its cash, cash equivalents, and short-term investments held at SVB to other financial institutions. At present, the company holds less than 5% of its cash, cash equivalents, and short-term investments with SVB and intends to hold a de minimis amount with SVB going forward, pending the resolution of SVB's closure and receivership under the Federal Deposit Insurance Corporation. In addition, since November 2022, the company has maintained a five-year loan facility agreement with MidCap Financial and SVB, comprised of a term loan of up to $100 million and a revolving line of credit of up to $25 million. At present, the company has $80 million in outstanding debt to MidCap and SVB under the Agreement. The company is currently, and at all times has been, in compliance with the Agreement, including all financial covenants. The company notes that no material impact to operations has occurred or is expected to occur in connection with SVB's closure and receivership under the FDIC."

10:13 EDT Billtrust announces Scott Collins joins as Chief Commercial Officer - Billtrust has announced that Scott Collins has joined the company as Chief Commercial Officer. Collins comes to Billtrust from HireRight where he served as Chief Commercial Officer and Global Managing Director, the company said. "He joins Billtrust at a critical period when finance leaders are turning to accounts receivable automation and digital payments to modernize their operations, improve customer satisfaction and become more efficient. Scott joins Billtrust following other recent appointments including Sunil Rajasekar as Chief Executive Officer and Grant Johnson and Bob Purcell as Chief Marketing Officer and Chief Financial Officer, respectively," the company added.

10:07 EDT GlucoTrack focused on completing feasibility assessment of implant life - GlucoTrack announced that Paul Goode, PhD, President and CEO has provided a shareholder update letter. The letter read in part, "We continue to make progress on our flagship Glucotrack non-invasive monitor. Our development team began our Gen 2 redesign program as a project to miniaturize the Gen 1 technology into a smaller wireless ear clip that would connect to a smartphone via Bluetooth. As our miniaturization project progressed, the glucose sensing landscape evolved as continuous glucose monitoring devices in the market reached similar accuracy as the conventional fingerstick blood glucose monitoring devices. This inevitably raised the regulatory bar for any glucose sensor performance, as regulatory bodies such as the FDA could now point to the accuracy levels of BGM and CGM alternatives already available to the patient. In addition, the Company recognized the advent and significant growth of digital health. Particularly, CGM companies set a new bar for a mobile experience with diabetes data and its associated cloud management, with BGM companies quickly following. Also, from a user experience perspective, while a 60 second measurement time may have been acceptable to the market in the past, we determined this is no longer the case, and that we needed to significantly reduce the time it took to complete a measurement. As a result of these changing dynamics, we concluded that the Gen 2 project scope not only had to reduce the size of our device, but also had to improve the user experience and to significantly improve sensor accuracy. Accordingly, the Company had to return to a research mode to design, develop, and test a new, more innovative device that would meet this criteria and to invest in software development to ensure that the Gen 2 product would be supported by both iOS and Android devices with a cloud-based infrastructure. By the end of 2022 we had a clinical prototype of a newly designed system. This system utilizes ultrasound-only sensor technology, reduces the overall cost and complexity of the device, and reduces the measurement time from 60 seconds to 2 seconds. Initial testing produced promising results, suggesting measurement accuracies could be obtained similar to those of conventional, already in-the-market CGM technologies. Continued testing however, exposed certain human factors that complicated consistent sensor placement. We have identified several mechanical techniques to address this challenge and we expect to complete this process and begin our first-in-human study in the second quarter of 2023. Collecting data for sensor characterization and algorithm development will be the primary goals of the FIH study. The results of this study will also drive the development of the commercial version of the device, which is expected to commence late in the third quarter of 2023. Once the development of the commercial device version is complete, we intend to conduct a scaled down version of the FDA pivotal trial to resolve any lingering device performance or human factors issues prior to executing the larger pivotal trial for FDA submission...Our focus now is to complete the feasibility assessment of achieving a multi-year implant life. In parallel, we have initiated an implantable electronics design effort. A paper-based design has been completed, and a physical mock-up is expected in the second quarter of 2023, with a targeted prototype design for an animal study to commence in the third quarter of 2023. By the end of 2023 we intend to have completed the feasibility assessment based on bench data and sensor life modeling/prediction, have bench data demonstrating at least six months of sensor life without significant degradation, have animal data demonstrating at least three months of sensor life without significant degradation, and have initiated a human clinical device/system design and development program."

10:03 EDT ACI Worldwide partners with RedAbierta for real-time payments in Honduras - ACI Worldwide announced a partnership with financial technology company RedAbierta to power real-time payments in Honduras. RedAbierta, the central infrastructure provider in Honduras, will leverage two ACI solutions, ACI Enterprise Payments Platform and ACI Low-Value Real-Time Payments, to build the domestic real-time payments central infrastructure in the Central American country and help financial institutions connect to the new scheme. Expected to go live in Q2 of 2023, the scheme will enable banks and other financial institutions to offer new digital payments services to customers. By launching real-time payments in Honduras, participating financial institutions and payments service providers aim to drive economic growth and promote financial inclusion among large parts of the underbanked population in Honduras.

10:00 EDT Gaotu Techedu falls -13.4% - Gaotu Techedu is down -13.4%, or -64c to $4.09.

10:00 EDT TAL Education falls -16.5% - TAL Education is down -16.5%, or -$1.12 to $5.67.

10:00 EDT Western Alliance rises 36.7% - Western Alliance is up 36.7%, or $9.59 to $35.71.

09:59 EDT CME Group reports 'highest daily volume on record' seen on March 13 - CME Group reported its "highest daily volume on record," with 66,250,862 contracts traded on March 13. This follows the company's fourth highest daily volume on March 10, when 56,433,765 contracts traded, the company noted. "Given the extreme volatility in today's environment, exacerbated by the recent failures of Silicon Valley Bank and Signature Bank, we are seeing a flight to futures as participants turn to our deeply liquid markets. The importance of risk management cannot be overstated. Our futures and options on futures products are doing what they were designed to do, as investors seek to protect their portfolios amid heightened volatility," said CME Group Chairman and CEO Terry Duffy.

09:49 EDT Ambit Biosciences Corp trading halted, volatility trading pause

09:47 EDT Small Cap Bear 3x falls -9.8% - Small Cap Bear 3x is down -9.8%, or -$3.47 to $31.80.

09:47 EDT TAL Education falls -11.3% - TAL Education is down -11.3%, or -77c to $6.03.

09:47 EDT Western Alliance rises 52.5% - Western Alliance is up 52.5%, or $13.72 to $39.84.

09:44 EDT First Republic trading resumes

09:42 EDT Comerica trading resumes

09:40 EDT Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences - Mindset Pharma (MSSTF) has been made aware that Reunion Neuroscience (REUN) has filed a lawsuit against Mindset in the United States District Court for the District of New Jersey asserting, among others, inventorship and co-ownership of one of Mindset's patents, inequitable conduct, and breach of contract. Mindset disagrees with and denies the allegations set forth from Reunion. The Company plans to vigorously defend itself against this lawsuit.

09:37 EDT Comerica trading halted, volatility trading pause

09:36 EDT Western Alliance trading resumes

09:33 EDT Hutchmed announces closing of fruquintinib license to Takeda - HUTCHMED (HCM) announces that, further to its announcement on January 23, 2023 and following the completion of customary closing conditions including antitrust regulatory reviews, the exclusive license agreement with a subsidiary of Takeda Pharmaceutical (TAK) to further the global development, commercialization and manufacture of fruquintinib outside China has closed. Takeda is now responsible for the development, commercialization and manufacture of fruquintinib in all included territories worldwide excluding mainland China, Hong Kong and Macau, where it is marketed by HUTCHMED. Following the closing of the exclusive license agreement, HUTCHMED will receive $400M shortly, and is eligible to receive up to $730M in additional potential payments relating to regulatory, development and commercial sales milestones, as well as royalties on net sales. Marketing authorization submissions in the U.S., Europe and Japan are planned to complete in 2023, with the rolling submission to the U.S. Food and Drug Administration initiated in December 2022.

09:31 EDT Western Alliance trading halted, volatility trading pause

09:23 EDT NanoVibronix announces results from UroShield independent product trial - NanoVibronix announced the evaluation results for its UroShield device, presented at a recent medical conference by clinicians from the Royal National Orthopaedic Hospital, or RNOH. The report concluded that the company's UroShield device showed a decrease in the number of blockages and infections and an increase in catheter satisfaction in the patients studied. In addition, evaluators concluded that the device has the potential to improve quality of life and reduce healthcare associated costs for patients with spinal cord injuries who experience recurrent blockages or infections and who have complicated catheter issues.

09:21 EDT Volcon, GLV, ElectraMeccanica enter assembly agreement - Volcon (VLCN) and ElectraMeccanica Vehicles Corp. (SOLO) jointly announced that Volcon's manufacturing partner, GLV, has chosen ElectraMeccanica's recently commissioned, 235,000-square-foot HQ facility in Mesa, AZ for final assembly of Volcon's next generation Grunt EVO and Runt fat-tired electric motorcycles.

09:20 EDT Crypto names extend gains as bitcoin soars to nine-month high above $26,000 - Stocks levered to bitcoin prices are extending their overnight gains as the cryptocurrency continues to rebound, rising another $1,500 this morning above $26,500 - the highest level since June of 2022. Bit Digital (BTBT) is up 10.3% at $1.29 per share, Riot Blockchain (RIOT) is up 10.4% at $6.90, Marathon Digital (MARA) is up 12.7 at $7.55, MicroStrategy (MSTR) is up 8% at $240.94 and Coinbase Global (COIN) is up 10.2% at $65.20.

09:17 EDT Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners - Boeing and Saudi Arabian Airlines announced the national flag-carrier will grow its long-haul fleet with the selection of up to 49 787 Dreamliners. SAUDIA is set to purchase 39 787s, with a further 10 options, utilizing the outstanding efficiency, range and flexibility of the Dreamliner to sustainably grow its global operation. The agreement will include both 787-9 and 787-10 models. This agreement is part of Saudi Arabia's wider strategic plan to transform the country into a global aviation hub. In total, Saudi Arabian carriers announced today their intent to purchase up to 121 787 Dreamliners in what will be the fifth largest commercial order by value in Boeing's history. This will support the country's goal of serving 330 million passengers and attracting 100 million visitors annually by 2030.

09:15 EDT Riyadh Air choses Boeing 787 Dreamliner to power its global launch - Boeing and Riyadh Air announced that the new Saudi Arabian carrier has chosen the 787 Dreamliner to power its global launch and support its goal of operating one of the most efficient and sustainable fleets in the world. Owned by Saudi Arabia's Public Investment Fund, Riyadh Air said it will purchase 39 highly efficient 787-9s, with options for an additional 33 787-9s. Based in the capital city, Riyadh Air will play a key role in growing Saudi Arabia's air transport network. This agreement is part of Saudi Arabia's wider strategic plan to transform the country into a global aviation hub. In total, Saudi Arabian carriers announced their intent to purchase up to 121 787 Dreamliners in what will be the fifth largest commercial order by value in Boeing's history. This will support the country's goal of serving 330 million passengers and attracting 100 million visitors annually by 2030.

09:12 EDT Cemtrex's Vicon launches new suite of AI-based anaytics - Cemtrex announced Vicon Industries has released a new suite of AI-based analytics in an enhanced Vicon Roughneck AI Camera series, further improving its unified VMS platform for controlling video, access control, license plate recognition, LPR, and other integrated applications. Vicon's enhanced lineup of Roughneck AI Cameras and latest VMS release - Valerus 23.1 - combine to deliver powerful object classification, tracking, recording and forensic searching. This tight integration between its enhanced cameras and Valerus further improves Vicon's established position as an end-to-end solutions provider. "Vicon continues to push the boundaries of next-generation AI security technology with these latest additions to the award-winning lineup of Roughneck Cameras," said Saagar Govil, Chairman and CEO of Cemtrex. "As the hub of an integrated security solution, Valerus continues to provide features users count on to make their job easier and more intuitive and adding AI edge-based analytics further enhances its complement of advanced features.

09:11 EDT Verisk Analytics launches 'Real-Time Decisions' product suite - Verisk has launched a new product suite that helps marketers of considered purchases such as insurance make real-time decisions during inbound consumer interactions. The new "Real-Time Decisions" product suite from Verisk Marketing Solutions empowers marketers to make split-second choices about how best to engage with consumers, enabling improved customer experiences and higher conversion rates.

09:10 EDT Digerati Technologies provides update on plan to list on Nasdaq - Digerati Technologies provides an additional update to its previously announced signing of a definitive business combination agreement with Minority Equality Opportunities Acquisition. MEOA and the Company are jointly preparing MEOA's second S-4/A registration statement regarding the business combination and MEOA's response to comments from the Securities and Exchange Commission Staff regarding the S-4/A that was filed on February 15, 2023. The merger will not close until the SEC declares the S-4 effective. The transaction also remains subject to NASDAQ approving MEOA's initial listing application in connection with the merger, approval of the merger by the shareholders of each of MEOA and Digerati, as well as other customary closing conditions. Prior to the filing of the next S-4/A registration statement, Digerati and Minority Equality Opportunities Acquisition Inc. will file, respectively, its Form 10-Q for the period ended January 31, 2023 and Form 10-K for the year ended December 31, 2022. As previously reported, the transaction results in a $105M enterprise valuation for Digerati and has been approved by the boards of directors of both Digerati and MEOA, with an expected closing in the second quarter of CY 2023, subject to the approvals mentioned in the second paragraph of this press release. As previously disclosed, the Business Combination Agreement was extended through April 28, 2023.

09:09 EDT Intapp selected by Practus to deliver risk, compliance solutions in cloud - Intapp (INTA) announced that virtual law firm Practus has selected Intapp Risk & Compliance, delivered in the Microsoft (MSFT) Azure Cloud, as its risk management and compliance suite. The Intapp Risk & Compliance cloud suite helps professionals quickly and thoroughly evaluate new business, onboard clients, and monitor relationships for compliance throughout the client lifecycle. As a part of this suite, Practus will use Intapp Conflicts to implement a centralized, AI-driven approach to ensuring all ethical, business, and subject-matter conflicts are addressed quickly and confidently. Intapp Conflicts will serve as a stable platform upon which Practus can manage their complex conflicts-checking process. "We are excited to be working with Practus to enhance their already collaborative, innovative, and consultative firm culture with conflict clearance capabilities they can depend on," said Nigel Riley, General Manager of Intapp Risk and Compliance Solutions. "Intapp Conflicts cloud is the first step in the firm's strategic approach to building a unified technology backbone for operations, freeing firm leadership to focus on client service."

09:08 EDT Meta Platforms canceling projects that are lower priority, duplicative - CEO Mark Zuckerberg said: "A leaner org will execute its highest priorities faster. People will be more productive, and their work will be more fun and fulfilling. We will become an even greater magnet for the most talented people. That's why in our Year of Efficiency, we are focused on canceling projects that are duplicative or lower priority and making every organization as lean as possible."

09:07 EDT JetBlue, Shell Aviation announce SAF collaboration at LAX - JetBlue and Shell Aviation announced a new collaboration bringing additional supply of sustainable aviation fuel, or SAF, to Los Angeles International Airport, or LAX, targeting commencement of delivery in the first half of 2023. Within the terms of the agreement, JetBlue is expected to take delivery of 10,000,000 gallons of blended SAF at LAX over the next two years and an option to purchase up to 5,000,000 gallons more in the third year, either at LAX or other airports in JetBlue's network.

09:07 EDT Scott Adams brings 'Dilbert' to Rumble's Locals - Rumble announced cartoonist and author Scott Adams has brought his comic "Dilbert" to Locals, its subscription-based platform. Annual and monthly subscribers now have access to exclusive content from the popular cartoonist. Adams launched a Locals community in 2020, where he has hosted a successful daily live stream, "Coffee with Scott Adams." The community contains over 200 "Micro Lessons" and a comic strip titled "Robots Read News" among other exclusive livestreams. The latest addition is "Dilbert Reborn," which adds to a variety of exclusive content available to the Scott Adams Locals community.

09:07 EDT Meta Platforms to lift hiring, transfer freezes after restructuring

09:06 EDT AvePoint adds new solutions to FedRAMP Authorization - AvePoint announced the addition of three new solutions to its FedRAMP Authorization as a Software as a Service company, signifying that AvePoint security controls have been rigorously evaluated and its SaaS solutions are verified for use within all federal agencies. Including new solutions in its FedRAMP Authorization reinforces AvePoint's continued commitment to upholding government security standards for all customers, including public sector and federal customers in the United States.

09:05 EDT Meta Platforms to reduce team size by around 10,000 people

09:04 EDT Mediahub selects Unruly as preferred SSP - Unruly announced it has been selected by media agency Mediahub as a preferred supply-side platform.

09:03 EDT Tactile Systems appoints Birkemeyer as Chief Financial Officer - Tactile Systems Technology (TCMD) announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Birkemeyer will succeed Brent Moen, who is retiring. Birkemeyer joins Tactile Medical from UnitedHealth Group Inc. (UNH). She began working for the company in 2014, heading finance for its Optum Operations business as Vice President, and later Senior Vice President, of Optum Operations Finance. Beginning in 2020, she served as Chief Financial Officer of Rally Health, a digital health company wholly owned by UnitedHealth Group, and most recently as Chief Financial Officer of UnitedHealth's Care Solutions portfolio.

09:03 EDT Microsoft partners with cloud gaming provider Boosteroid - Microsoft and Boosteroid announced a 10-year agreement to bring Xbox PC games to Boosteroid's cloud gaming platform. Boosteroid, which has its software development team in Ukraine, recently surpassed 4 million users globally and has become the largest independent cloud gaming provider in the world. The agreement will also enable Activision Blizzard PC titles to be streamed by Boosteroid customers after Microsoft's acquisition of Activision Blizzard closes. When combined with other partnerships recently announced by Microsoft, this will make games built by Xbox Game Studios, Bethesda and Activision Blizzard playable on multiple cloud gaming services and subscriptions. In addition to Ukraine itself, Boosteroid now serves gamers in the United States, United Kingdom and countries across the European Union. It operates through data center operations located in six U.S. states, as well as in the U.K., France, Italy, Spain, Sweden, Slovakia, Romania, Ukraine and Serbia.

09:02 EDT FSD Pharma renews shareholder intelligence to probe 'naked' short selling - FSD Pharma announced that it has renewed the service agreement with ShareIntel-Shareholder Intelligence Services to assist in ongoing investigations related to suspected naked short selling of the Company's common stock. Naked short selling, a form of market manipulation, is the illegal practice of short selling shares that have not been affirmatively determined to exist. Effectively, naked short selling creates artificial shares that do not exist in a company's capital structure. The Company's management over the course of the past few years, has been receiving several requests by concerned shareholders to explain the discrepancy between buying and selling data of HUGE stock by different banks and broker-dealers. The Company's management, along with its consultants and contractors, have been analyzing data on a daily basis for over a year now, including that of broker-dealers, clearing firms, and shareholder position management. In light of the data analyzed, the Company's management, for at least the past 12 months, has sent multiple correspondences with questions, to broker-dealers highlighting an imbalance in trade activity, for which management has received either no response or a generic, unsatisfactory reply. To this date, the company has not received a satisfactory response to shareholder inquiries related to discrepancies between buying and selling of HUGE stock. Despite being a drain on its resources, the inadequate, or complete absence of, responses have forced the Company to pursue additional avenues in order to provide clarity on this situation as part of its fiduciary responsibility to shareholders. The company is consulting with ShareIntel and others on the matter of retaining a law firm specialized on the subject. The Company intends to review historic and future data and consider prosecution of individuals or groups potentially engaged in any violations of securities laws, rules, and regulations related to naked short selling.

09:01 EDT Blue Apron launches Blue Apron Plus on Verizon +play - Blue Apron (APRN) announced the launch of Blue Apron Plus, a new savings program exclusively on Verizon's (VZ) +play platform, for customers to shop for, manage and save on their subscriptions, all in one place. The company is the first and only meal-kit provider on the +play platform to date. Blue Apron PLUS is a new monthly subscription managed through the +play platform for Verizon customers. Blue Apron PLUS customers will have access to exclusive savings on meal-kit subscriptions, including 35% off their first 5 eligible meal kit orders, then 15% off each eligible order after that. For a limited-time, Verizon customers can get 3 months of Blue Apron PLUS free. After the promotional period, Blue Apron Plus is $4.99 per month.

08:56 EDT Clearmind Medicine appoints Henry Kranzler to Scientific Advisory Board - Clearmind Medicine announced the appointment of Professor Henry Kranzler, M.D., as the newest member of its Scientific Advisory Board. Professor Kranzler is the Benjamin Rush Professor of Psychiatry, and Director of the Center for Studies of Addiction, at the University of Pennsylvania's Perelman School of Medicine. His research focuses on the genetics and pharmacological treatment of substance dependence, with emphasis on precision addiction medicine. His research has been continuously supported since 1987 by grants from the National Institutes of Health.

08:52 EDT Mawson Infrastructure confirms no exposure to Silvergate Capital and SVB - Mawson Infrastructure Group (MIGI) communicates to the market that it doesn't have any historical or current banking relations with either Silvergate Bank (SI) or Silicon Valley Bank (SIVB). Mawson does have a banking relationship with Signature Bank, amongst other banks. As of Monday evening Mawson has taken all actions to transfer the majority of its assets it held with Signature Bank to other financial institutions, and as a result of those transfers being successful will have no material exposure to Signature Bank. Mawson is also in the process of initiating additional banking relationships. Mawson has the greatest of sympathies for all that are affected in this difficult time.

08:41 EDT BYND Cannasoft announce plan to formulate CBD oil, brand with license in Israel - BYND Cannasoft Enterprise announced plans to formulate a proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel for its new artificial intelligence based device and its EZ-G device. BYND Cannasoft will utilize the knowledge and technology associated with its recent patent application to create various products, some of which will be combined with CBD oils at low concentrations or other non-drug oils to increase pleasure in intimate relationships. BYND Cannasoft plans to market these products for its new AI-based device and its EZ-G device, like that of the razor/razor blade model. By selling the durable base product at a low-profit margin, the Company can sell the associated proprietary consumable goods at a higher profit margin to generate recurring revenues. The Company intends to utilize the full license its Cannasoft Pharma subsidiary received from the Medical Cannabis Unit at the Ministry of Health of the State of Israel to engage in medical cannabis without direct contact with the substance to develop its proprietary CBD oils for its new AI-based device and its EZ-G device. BYND Cannasoft also plans to utilize its license to market additional cannabis products in Israel. Yftah Ben Yaackov, CEO and Director of BYND, said, "The Israeli cannabis market is a significantly growing market, and the field of medical cannabis generates hundreds of millions of dollars a year. Our Cannasoft Pharma subsidiary receiving a license from the Medical Cannabis Unit at the Ministry of Health of the State of Israel to engage in medical cannabis without direct contact with the substance is a key point in our business plan." Mr. Yaackov continued, "The products we plan to bring to market may provide additional treatment options and respond to the unmet medical needs of patients. We will continue to pursue these unmet needs in this growth-oriented market and our AI-based products."

08:40 EDT Datasea contributes to drafting the China Express Association tech requirements - Datasea is a digital technology corporation engaged in three converging and innovative business segments: 5G messaging, acoustic intelligence, and digital smart city technology in China. Today, the Company announced that Hangzhou Shuhai Zhangxun Information Technology, a subsidiary of the Chinese operating company contractually controlled by the Companycontributed to drafting the, "General Technical Requirements for 5G Messaging Services in the Express Delivery Industry" in collaboration with the China Express Association. Shuhai Zhangxun participated in drafting this document with ten other prominent industry participants including; Shuhai Zhangxun, YTO Express, ZTO Express, Shenzhen Sf Tyson, and Zhejiang Cainiao Supply Chain Management, etc. General Technical Requirements provide comprehensive coverage of the entire service chain, from network nodes to endpoints. It outlines 5G messaging, including its definition and characteristics, fundamental functions, service capabilities, application scenarios, and case analyses. Datasea's CEO, Liu Zhixin commented, " We are immensely proud and honored that Shuhai Zhangxun was given the opportunity to contribute to the creation of the General Technical Requirements for implementing 5G messaging applications in China's express delivery sector. This contribution not only signifies our commitment to innovation and excellence, but also demonstrates our leadership in the field. We believe that the General Technical Requirements will offer a solid foundation and technical direction for implementing 5G messaging applications and help unlock the potential of digital innovation in the industry and open up new opportunities for growth and development."

08:39 EDT DMG Blockchain Solutions holds no deposits with SVB, Silvergate, Signature - DMG (DMGGF) has held no deposits with Silvergate Bank (SI), Silicon Valley Bank (SIVB), nor Signature Bank (SBNY). DMG holds its cash with large banks ranked in the top 50 globally.

08:37 EDT Bowlero to acquire Paradise Lanes Entertainment Center in Washington State - Bowlero announced that it has entered into a definitive agreement to acquire Paradise Lanes Entertainment Center in Washington State. Paradise Lanes Entertainment Center is located in Tacoma, WA, 32 miles southwest of Seattle. This center features 32 bowling lanes, an arcade, billiards, a full service bar and restaurant, and VIP party rooms. The acquisition of Paradise Lanes Entertainment Center marks Bowlero Corp.'s 4th location in the state of Washington. "We are pleased to announce our continued expansion in the state of Washington," stated Brett Parker, President & Chief Financial Officer of Bowlero. "Our pipeline of acquisitions remains robust as we enter our first definitive agreement of the calendar year. We are pleased to continue our growth with this latest acquisition and look forward to welcoming this center to our portfolio." No terms for the transaction were given in the press release.

08:36 EDT iCoreConnect says LDS endorses iCoreVerify software - iCoreConnect announced the Louisiana Dental Services, the for-profit subsidiary of the Louisiana Dental Association, endorsement of iCoreVerify automated insurance verification software. iCoreVerify is LDA's second endorsed iCoreConnect product. LDA endorsed iCoreExchange encrypted HIPAA-compliant email in 2015.

08:35 EDT electroCore reports no direct exposure to SVB, Silvergate, Signature Bank - electroCore (ECOR) does not have direct exposure to Silicon Valley Bank (SIVB), Silvergate Bank(SI), or Signature Bank (SBNY). electroCore does not hold cash deposits or securities with these banking institutions, and currently holds corporate cash accounts with large global money center banks.

08:33 EDT Predictive Oncology engages LifeSci Advisors as strategic investor partner - Predictive Oncology announced that it has engaged LifeSci Advisors, a leading New York-based investor relations, IR, consultancy serving life science companies, to implement a comprehensive IR program that will include, among other key activities, targeting of and outreach to leading analysts and institutional investors, bank conference targeting, non-deal roadshows, corporate communications, and Key Opinion Leader events focused on AI and machine learning-assisted drug discovery. "Simply put, since assuming the role of CEO last November, I have been blown away by the untapped potential of our assets and capabilities, including our artificial intelligence drug discovery engine, PEDAL, that we can leverage against our extensive biobank of more than 150,000 tumor samples and 200,000 pathology slides to accelerate and de-risk drug discovery on behalf of academic institution and drug development partners," stated Raymond Vennare, Chief Executive Officer of Predictive Oncology. "With the global AI-assisted drug development market currently at $1.1 billion and growing at nearly 30% per year, we are indeed in the right place at the right time."

08:33 EDT Tivic Health says reduced final assembly production costs by 40% per unit - Tivic Health announced it has completed the supplier qualification and first article inspection of ALOM, one of two new partners announced in Q4 of 2022. The supplier qualification and successful first article inspection help confirm that Tivic's production process is under statistical control and produces safe products in compliance with Tivic's specifications and applicable regulatory requirements. "This is an important advancement that supports our initiative to reduce costs and improve margins," said Ryan Sabia, COO of Tivic. "Working with ALOM will allow us to decrease our third-party logistics costs by up to 30% and we have reduced our overall final assembly production costs by 40% per unit."

08:32 EDT Ultragenyx appoints Crombz as Chief Medical Officer - Ultragenyx Pharmaceutical announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role. Dr. Crombez currently serves as Ultragenyx's chief medical officer for gene therapy and inborn errors of metabolism.

08:29 EDT Colt selects Amdocs for network transformation - Amdocs announced it has been selected by digital infrastructure company Colt Technology Services to deliver a powerful, robust platform that digitalizes and automates Colt's global product and service inventory for an enhanced customer experience. The collaboration will facilitate widespread enhancements to Colt's service delivery, engineering and network operations, giving Colt teams the ability to deliver a wide range of provisioning changes, capacity planning and fault-resolution services across a single, connected platform, in real-time and across borders. It will also enable greater self-service options for customers to manage their own infrastructure changes if they choose to.

08:27 EDT CLS Holdings says City Trees maintains #1 concentrate brand ranking in Nevada - CLS Holdings USA announced City Trees, is again ranked as the number one concentrate brand by units sold in Nevada. From January to December 2022, CITY TREES generated $21.2M in retail sales and sold 1.1M units of vapes and dabbable concentrates, according to the cannabis retail tracking firm, BDS Analytics. CLS Holdings has grown by 43% YoY as a house brand and secured a 6.5% brand share within the vape category. City Trees products include disposable vapes, cartridges, dab-oil syringes, tinctures, and various live and cured resin concentrates. PUF vape cartridges and Naked City Pre-Rolls are the newest additions to the CLS house brand and YTD, they have procured a 9.8% market share across brands.

08:21 EDT Perspective Therapeutics and PharmaLogic collaborate in theranostics - Perspective Therapeutics' wholly-owned subsidiary Viewpoint Molecular Targeting signed a Master Services Agreement with PharmaLogic Holdings, a contract development and manufacturing organization and radiopharmaceutical manufacturer, for the development and production of theranostic candidates VMT-01 and VMT-alpha-NET. The radiopharmaceuticals are currently in development for the diagnosis and treatment of metastatic melanoma and neuroendocrine tumors, respectively. PharmaLogic will produce and supply doses of VMT-01 and VMT-alpha-NET for use in Perspective's early-stage clinical trials. This will complement the existing radiopharmaceutical GMP capability that Perspective already has at its mid-west site.

08:17 EDT BIO-key, BeyondTrust announce integrated partnership - BIO-key International announced the integration of their PortalGuard Identity-as-a-Service, IDaaS, platform with BeyondTrust, a worldwide leader in intelligent identity and access security. This partnership and technology integration expands the presence of both companies in the partner ecosystem, provides enhanced security for privileged remote access and delivers a new level of confidence for customers that only authorized users are accessing critical systems, data, and applications. BIO-key's PortalGuard, integrated with BeyondTrust's Privileged Remote Access solution that controls, manages, and audits the access of privileged employees, vendors, developers, and cloud ops engineers, now offers BeyondTrust customers a wide range of flexible authentication options, including Identity-Bound Biometrics. The partnership further builds BIO-key's integrations into the ecosystem of leading providers of IAM, PAM and Identity Governance and Administration solutions, as enterprises look to achieve a holistic identity-first and zero trust strategy. BIO-key's solutions address critical authentication gaps by introducing Identity-Bound Biometric methods to expand the security and convenience of efficient access to critical systems, data, and applications from anywhere, at any time. "The integration between BIO-key's PortalGuard platform and BeyondTrust's Privileged Remote Access solution will provide customers with a new level of confidence that only authorized remote users are gaining access," said Galen Rodgers, Vice President of Channel for BIO-key International. "Combining the ability to positively identify the person requesting access using BIO-key's Identity-Bound Biometrics with BeyondTrust's ability to manage and audit remote access, customers experience the benefits of greater risk reduction and a comprehensive PAM solution that is designed to meet the needs of a modern organization."

08:16 EDT Corteva, Bunge, Chevron team to produce lower carbon winter canola - Corteva (CTVA), Bunge (BG) and Chevron (CVX), announced a commercial collaboration to introduce proprietary winter canola hybrids that produce plant-based oil with a lower carbon profile. The goal is to increase the availability of vegetable oil feedstocks primarily for the growing domestic renewable fuels market. The companies plan to introduce the winter canola crop into the southern United States with an intention to create a new revenue opportunity for farmers with a sustainable crop rotation. The proprietary winter canola hybrids from Corteva can be used in a double crop system, following soybeans or cotton. "We're pleased to work with Bunge and Chevron to bring a new option in the southern U.S. that will deliver solutions for farmers to increase productivity and sustainability on their acres, as well as contribute to the need for renewable and less carbon-intensive fuel options," said Chuck Magro, CEO, Corteva Agriscience. Bunge Chevron Ag Renewables, the joint venture between Bunge and Chevron, plans to contract with farmers to purchase the harvested winter canola crop and use the oil to produce renewable fuel. In addition to providing farmers a new income opportunity, adding winter canola to a rotation provides a cover crop which can enhance soil health by holding more nutrients, water, and carbon in the soil. A pilot program is expected to be conducted in the 2022-23 growing season to fine-tune best management practices.

08:15 EDT Osisko Development announces proposed reduction in exercise price of warrants - Osisko Development Corp. has received the required approvals of the Company's Board of Directors and made an application to the TSX Venture Exchange to reduce the exercise price of the common share purchase warrants issued in 2022 . The proposed Amendments remain subject to the approval of the TSX Venture Exchange. The exercise price for the Warrants have been reduced in accordance with the policies of the TSX Venture Exchange and are expected to become effective prior the end of March 2023, without the need to obtain warrantholder approval.

08:14 EDT Immutep announces initiation of Phase II/III trial for eftilagimod alpha - Immutep announced the initiation of AIPAC-003, an integrated Phase II/III trial to evaluate eftilagimod alpha in combination with paclitaxel for the treatment of metastatic HER2-neg/low breast cancer. Regulatory approval has been received in the US and Institutional Review Board approval has been received in Spain, with approvals in additional countries anticipated to follow shortly. The first patient is expected to be enrolled in early Q2 CY2023. Immutep CEO, Marc Voigt, said: "With its novel mechanism of action to activate antigen-presenting cells, efti has to date safely improved clinical outcomes from anti-PD-(L)1 therapies and standard-of-care chemotherapy. We look forward to AIPAC-003 building upon the encouraging synergy seen in our previous Phase IIb trial in metastatic breast cancer, especially with its three key adaptations: same day administration of efti plus paclitaxel, this dual IO-chemotherapy treatment continuing until disease progression, and a new primary endpoint of overall survival. The selected Phase II/III trial design allows us to move forward with a risk-balanced approach in MBC, as we continue our prioritized late-stage clinical development with anti-PD-1 therapy in 1st line head & neck squamous cell carcinoma and 1st line non-small cell lung cancer." The Company and the US Food and Drug Administration agreed to the integrated Phase II/III trial design for AIPAC-003 that will help inform a Biologics License Application. Additionally, the trial design incorporates feedback from Scientific Advice meetings with the European Medicines Agency to support a Marketing Authorisation Application. With respect to the late-stage clinical development of efti, the Phase II portion of the MBC trial, the ongoing randomized/controlled Phase II trial in 1st line HNSCC, and the initiation of the registrational trial in 1st line NSCLC are included in the budget and have no impact on the Company's expected cash runway to the end of the 1st half of calendar year 2024.

08:12 EDT Worksport's $4M European machine line arrives at New York factory - Worksport announces that its US$4M custom European manufacturing line has arrived at the Company's 222,000 sq. ft. factory in Western N.Y. - one month earlier than initially scheduled. The Company anticipates making final preparations for the American production of its advanced, hard-folding tonneau cover -- and later, the proprietary SOLIS solar-charging tonneau cover -- for the growing pickup truck market. The Company plans to start installing the manufacturing right away and expects the installation to take several weeks, after which it plans to start several weeks of training before it will conduct numerous test runs. "All of us at Worksport were so proud to have this advanced European manufacturing line delivered to our New York factory," said Worksport CEO Steven Rossi. "It confirms our strategy of sourcing this machine so that American production of our hard-folding tonneau covers can begin. We anticipate beginning installation and training immediately so that we can deploy the manufacturing line as soon as possible. And when that happens, we believe Worksport will be well on the way toward our long-predicted goal of revenue growth."

08:11 EDT Microchip expands secure authentication IC portfolio with six products - Microchip Technology has expanded its secure authentication device portfolio with six new products in its CryptoAuthentication and CryptoAutomotive IC families that meet Common Criteria Joint Interpretation Library High rated secure key storage and support certified algorithms that comply with the Federal Information Processing Standard. This portfolio of secure authentication devices lowers the barrier to entry and enables developers of products for new segments and applications to implement trusted authentication to prevent counterfeiting, improve quality control and safeguard the user experience. As counterfeits become prevalent across many industries, the need to implement embedded trust in many designs is critical. Microchip added five new products to its existing portfolio of CryptoAuthentication ICs. Those ICs are hardware-based secure storage that is intended to keep secret keys hidden from unauthorized attackers: ECC204: ECC-P256 signature and Hash-based Message Authentication Code; ECC206: Two-pin parasitic power, ECC-P256 signature and HMAC; SHA104: Client SHA256 MAC; SHA105: Host SHA256 CheckMAC;SHA106: Two-pin parasitic power and client SHA256 MAC. The sixth new device is designed for the automotive market. The TA010 with ECC signature and HMAC is an AEC-Q100 Grade 1-qualified CryptoAutomotive IC that enables OEMs to implement secure authentication into their design without requiring costly modifications and to meet security requirements for future generations of their vehicles.

08:09 EDT ShockWave Medical announces U.S. launch of new peripheral IVL catheter - Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration. The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries. "Shockwave L6 is another example of our team's commitment to developing technologies to address specific market needs while still maintaining the safety, effectiveness and ease of use of our core IVL technology," said Doug Godshall, Chief Executive Officer of Shockwave Medical. "We are pleased with the success of our limited release and the great feedback we have received from our customers. We now look forward to offering Shockwave L6 as an additional IVL option for the most complex and high-risk large vessel cases."

08:07 EDT Imax partnering with EntTelligence for audience measurement platform - Imax and EntTelligence signed a new agreement that gives Imax access to theatrical impression-based analytics. Under the agreement, Imax will gain access to EntTelligence's platform, which provides analysis from over 3,000 theaters. EntTelligence's proprietary approach homogenizes observed information from hundreds of theater chains, parses data by market, and offers features including daypart analysis where users can determine audience exposure of content including the ads/trailers within the given auditoriums.

08:06 EDT MeiraGTx expects cash to fund requirements into 4Q24 - As of December 31, 2022, MeiraGTx had cash and cash equivalents of approximately $115 million, as well as approximately $21 million in receivables due from Janssen from the fourth quarter of 2022. The Company believes that with such funds, as well as anticipated milestones from Janssen, it will have sufficient capital to fund operating expenses and capital expenditure requirements into the fourth quarter of 2024.

08:05 EDT ViaSat to provie in-flight connectivity to additional Delta aircraft - Viasat's (VSAT) in-flight connectivity solution will be installed on a total of more than 1,000 Delta Air Lines (DAL) aircraft. This confirms Delta has selected Viasat IFC services for its widebody fleets, including all active aircraft in its Airbus A330, Airbus A350, and Boeing 767 fleets. The Airbus 220 and upcoming deliveries on the Boeing 737MAX will be outfitted and serviced by Viasat. Delta is on track to offer the service on more than 700 Viasat-equipped aircraft by the end of 2023.

08:02 EDT Univar to be acquired by Apollo Global funds for $8.1B - Univar Solutions (UNVR) and Apollo (APO) announced that funds managed by affiliates of Apollo have entered into a definitive merger agreement to acquire the company in an all-cash transaction that values the company at an enterprise value of approximately $8.1B. The transaction includes a minority investment from a wholly owned subsidiary of the Abu Dhabi Investment Authority. The agreement provides that Univar Solutions shareholders will receive $36.15 per share in cash, which represents a 20.6% premium to the company's undisturbed closing stock price on November 22, 2022. The transaction consideration also represents a premium of 33.6% to the volume-weighted average price of Univar Solutions for the 30 trading days ending on November 22, 2022. The transaction is expected to close in the second half of 2023, subject to customary closing conditions, including approval by Univar Solutions shareholders and receipt of regulatory approvals. The transaction is not subject to a financing condition. Upon completion of the transaction, shares of Univar Solutions common stock will no longer trade on the New York Stock Exchange, and Univar Solutions will become a privately held company. Univar Solutions will continue to operate under the Univar Solutions name and brand and maintain a global presence.

07:49 EDT Cvent to be acquired by Blackstone for $8.50 per share in cash - Cvent (CVT) announced that it has entered into a definitive agreement to be acquired by an affiliate of private equity funds managed by Blackstone (BX) in a transaction valued at an enterprise value of approximately $4.6B. Under the terms of the agreement, Cvent stockholders will receive $8.50 per share in cash, representing a premium of 52% to the volume weighted average share price over the 90 days prior to January 30, the day before media reports of a potential transaction were published. A wholly owned subsidiary of the Abu Dhabi Investment Authority, or ADIA, will be a significant minority investor alongside Blackstone as part of the transaction. Cvent has approximately 22,000 customers globally in the corporate, non-profit, higher education and hospitality sectors as of December 31, 2022. Since its founding in 1999, Cvent has helped manage more than 5M events, and lists over 302,000 hotels and venues as of December 31, 2022 on the Cvent Supplier Network, an online platform with tools to search, negotiate and contract with hotels and venues for event space. Following the recommendation of a special committee composed entirely of independent and disinterested directors, the Cvent board of directors unanimously approved the merger agreement. The transaction is expected to close mid-year 2023, subject to the satisfaction of customary closing conditions, including receipt of approval by Cvent's stockholders and required regulatory approvals. Upon completion of the transaction, Cvent's common stock will no longer be publicly listed, and Cvent will become a privately held company. Blackstone has received a fully committed $1B credit facility as part of the financing of this transaction.

07:46 EDT Cvent to be acquired by Blackstone for $8.50 per share

07:41 EDT Nextech3D.ai launches enhanced AR mobile app for live events - Nextech3D.AI announced enhanced features for trade show managers and event professionals in the latest update to its popular event app. The app combines the current MapD event management solutions technology with ARway, the AI-powered Augmented Reality Navigation platform with a disruptive no-code, no-beacon spatial computing solution, creating an industry-first augmented reality / artificial intelligence combined solution for event management providers.

07:38 EDT Agenus announces 2023 catalysts, objectives - Additional 2023 Catalysts and Operational Objectives: Complete enrollment of the Phase 1b study of AGEN2373 and botensilimab in melanoma. Initiate combination cohorts of AGEN1571 with botensilimab and balstilimab. Potential income from existing and future collaborators. Advance 7 existing clinical collaborations evaluating combinations of external agents with our PD-1 and CTLA-4 antibodies sponsored and executed by partners.

07:37 EDT Abeona Therapeutics announces update on AAV ophthalmology program - Abeona Therapeutics announced three internally developed investigational preclinical gene therapy product candidates from its ophthalmology program. Abeona's preclinical programs are investigating the use of novel adeno-associated virus capsids in therapies for serious genetic eye diseases. Preclinical Product Candidate ABO-504 for Stargardt Disease: Abeona's internal research and development team developed ABO-504, which is designed to efficiently reconstitute the full-length ABCA4 gene by implementing a dual AAV vector strategy using the Cre-LoxP recombinase system. In May 2021 at the Association for Research in Vision and Ophthalmology Annual Meeting, Abeona reported preclinical data demonstrating the ability of the dual AAV vector system to produce full length ABCA4 protein in cell culture. Recent proof-of-concept studies have extended these findings by showing expression of ABCA4 mRNA and full-length ABCA4 protein in the retina of subretinally dosed abca4-/- knockout mice, at levels similar to endogenous ABCA4 in wild-type animals. Preclinical Product Candidate ABO-503 for X-linked Retinoschisis: ABO-503, composed of a functional human RS1 packaged in the novel AIM capsid AAV204, has shown preclinical efficacy following delivery to the retina in a mouse model of XLRS. Preclinical studies have demonstrated robust RS1 expression in the retina, improved cone photoreceptor density and overall photoreceptor cell survival, as well as a restoration of outer retina architecture. Preclinical Product Candidate ABO-505 for Autosomal Dominant Optic Atrophy: ABO-505 is designed to express a functional copy of human Opa1 in the retina following para-retinal injection. AB0-505 aims to take advantage of the robust optic nerve and retinal ganglion cell transduction ability of AAV204 to deliver its genetic payload to the cells most affected by ADOA.

07:35 EDT IperionX signs MOU with SLM Solutions for spherical titanium metal powders - IperionX announced the signing of a non-binding memorandum of understanding, or MOU, with SLM Solutions Group, a metal additive manufacturing systems company, for the potential supply of spherical titanium metal powders from IperionX's planned Titanium Demonstration Facility, or TDF, in Virginia to SLM. SLM is an international provider of metal 3D printing solutions serving customers with an installed base of over 850 systems and 1,400 lasers globally, having invented selective laser melting and pioneered metal additive manufacturing using metal powders via the Laser Powder Bed Fusion additive manufacturing modality. This MOU with two leading metal AM technology companies could offer the first 100% recycled titanium metal powders to SLM's extensive global customer base.

07:33 EDT Aehr Test Systems receives $6.7M order for FOX WaferPak full water Contactors - Aehr Test Systems announced it has received a $6.7M order from its lead silicon carbide test and burn-in customer for multiple WaferPak full wafer Contactors to meet their increased production capacity needs for silicon carbide power semiconductors for the electric vehicle market. This customer is a leading Fortune 500 supplier of semiconductor devices with a significant customer base in the automotive semiconductor market. Gayn Erickson, President and CEO of Aehr Test Systems, commented, "We are excited about this customer's continued production ramp and new design wins using our wafer level test and burn-in systems and WaferPaks. This WaferPak order is about half of the total WaferPak Contactors needed for the FOX-XP wafer level test and burn-in systems previously ordered by this customer and announced in January. These WaferPaks are expected to be delivered beginning this current fiscal quarter and through our fiscal first quarter 2024 ending August 31, 2023."

07:33 EDT Biohaven to present anti-seizure results of BHV-7000 - Biohaven will present an oral and poster presentation demonstrating the preclinical efficacy and initial Phase 1 safety and tolerability of BHV-7000, a novel activator of heteromeric Kv7.2/7.3 potassium channels, on the 2023 American Society for Experimental Neurotherapeutics Annual Meeting virtual platform, taking place March 13-15, 2023. Steven Dworetzky, SVP of Kv7 Strategy and Development at Biohaven, said, "The preclinical data we are presenting at ASENT today demonstrate that activating Kv7.2/7.3 with BHV-7000, a compound that is structurally and pharmacologically distinct from ezogabine, produced concentration-dependent hyperpolarization of the resting membrane potential, potentiated meaningful increases in action potential threshold, exhibited significantly lower GABAA activity than ezogabine, and delivered potent anti-seizure efficacy in the maximal electroshock seizure model, without negatively impacting neurobehavior. Further, in the Phase 1 single ascending dose / multiple ascending dose clinical trial, BHV-7000 was well-tolerated at single doses up to 100 mg and multiple doses up to 40 mg per day for 15 days. Most adverse events were mild and resolved spontaneously, and there were no serious or severe adverse events or dose-limiting toxicities reported. Importantly, in BHV-7000 treated subjects in the MAD study, CNS-related adverse events typically associated with other anti-seizure medications were not reported."

07:32 EDT OptimizeRx authorizes $15M share repurchase program - OptimizeRx announced that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15M of its outstanding common stock. "We are fortunate to start 2023 with a strong working capital position and believe we are firmly placed to benefit from the scalability inherent in having the nation's largest in workflow point-of-care network; this share repurchase program reflects the long-term confidence we have in our business and our belief that our shares are undervalued," commented Will Febbo, OptimizeRx CEO.

07:29 EDT Gamesquare Esports receives final court approval for Engine Gaming arrangement - GameSquare Esports (GMSQF) and Engine Gaming and Media (GAME) announced that they have received approval from the Ontario Superior Court of Justice to complete the previously announced plan of arrangement under the Business Corporations Act pursuant to which Engine Gaming will acquire all of the issued and outstanding common shares of GameSquare at an exchange ratio of 0.08262 of an Engine Gaming common share for each GameSquare Share. The Arrangement was previously approved by shareholders of both GameSquare and Engine Gaming and remains subject to the satisfaction or waiver of the closing conditions contained in the arrangement agreement. Upon closing of the transaction, GameSquare shareholders are expected to own approximately 60% of combined company, and Engine Gaming shareholders are expected to own approximately 40% of the combined company, which will trade on the NASDAQ and TSX Venture Exchange under Engine Gaming's ticker symbol "GAME." The combined entity is expected to change its name to "GameSquare, Inc." and retain the "GameSquare" brand globally.

07:27 EDT Alterity granted composition of matter patent, exclusive license agreement - Alterity Therapeutics announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office has now been granted. The patent, entitled "Compounds for and methods of treating diseases", covers more than 100 novel compounds with an acyl hydrazone structure and provides 20 years of exclusivity. Alterity also announced a Licensing Agreement for the new patent and a sub-licensing agreement for PBT2 to Professor Colin Masters, M.D., A.O., to advance these compounds for the treatment of Alzheimer's and related diseases. Under the license agreement, Alterity grants the entire rights to the AH patent as well as an exclusive worldwide license to develop and commercialize both AH and PBT2 in Alzheimer's disease. In exchange, Alterity is entitled to future royalties of net sales from the assets. The acyl hydrazone patent is based on a new scaffold that is distinct from those specified in recent patents granted to Alterity and includes more than 100 novel small molecules, at least one of which has demonstrated efficacy in an animal model of dementia.

07:24 EDT Leidos protests Department of the Treasury TCloud award - Leidos (LDOS) has protested the Department of the Treasury's roughly $1.3B TCloud award to SAIC (SAIC), according to a post to the site of the Government Accountability Office. The GAO has until a due date of June 20 to issue a ruling, the post notes. Reference Link

07:23 EDT Gilat Satellite announces SES certified SkyEdge IV platform - Gilat Satellite Networks announced that SES has certified the SkyEdge IV platform for O3b mPOWER, O3b, and SES-17. "After the completion of rigorous testing on both our geostationary satellite SES-17 and medium earth orbit systems O3b and O3b mPOWER, we are confident that Gilat's multi-orbit SkyEdge IV platform meets our requirements for centralized management, high reliability and performance. We believe Gilat's SkyEdge IV is an ideal platform that can best serve our enterprise customers as well as mobile networks, maritime and cruise operators regardless of the orbit their networks is on," said Saba Wehbe, Vice President of Service Engineering & Delivery at SES.

07:22 EDT SpringBig announces two-way enrollment integration with Alleaves - springbig introduced a new integration with Alleaves, an industry-leading seed-to-sale tech company. Alleaves and springbig have developed a two-way integration that will ease the process of growing and maintaining a strong loyalty and communications program. With the integration, consumers will have the opportunity to sign up for a dispensary's loyalty and communications program through any of springbig's enrollment methods. Once a consumer has signed up for a loyalty and communications program, their profile will automatically sync to the dispensary's point-of-sale system. "We are thrilled to launch a new integration that will elevate the work of entrepreneurs throughout the cannabis industry," said Jeffrey Harris, CEO of springbig. "Alleaves is an incredible partner that shares our desire to provide solutions for cannabis innovators looking to adapt within a rapidly evolving industry. Moreover, this integration will provide consumers with more tools to connect with their favorite dispensaries."

07:19 EDT Parsons to acquire IPKeys Power Partners - Parsons Corporation announced that it has entered into a definitive agreement to acquire IPKeys Power Partners. "IPKeys Power Partners enhances Parsons' critical infrastructure protection capabilities through comprehensive cloud-based cybersecurity, software solutions that operate at the intersection of information and operational technology,, and technologies that will help accelerate the global clean energy transition," the company said. The acquisition brings IPKeys' established customer base, expanding Parsons' presence in two rapidly growing end markets: grid modernization and cyber resiliency for critical infrastructure. "The addition of IPKeys brings important software platforms and capabilities that strengthen our integrated solutions that protect critical infrastructure," said Carey Smith, Parsons' chair, president, and chief executive officer. "A natural extension of our growth strategy, this acquisition reinforces our position in the critical infrastructure protection market, enhances our customer base, spans both of our business segments, and extends our capabilities into adjacent markets. I look forward to welcoming the IPKeys team to the Parsons family as we continue delivering critical resiliency solutions that protect society in the face of increasing and evolving threats." The transaction is valued at $43 million and is consistent with Parsons' strategy of completing accretive acquisitions of companies with revenue growth and adjusted EBITDA margins of 10 percent or greater, while adding critical intellectual property that strengthens the company's existing portfolio. IPKeys Power Partners will be primarily integrated into Parsons' Connected Communities business unit and, specifically, the Parsons X digital accelerator organization.

07:16 EDT Bannix Acquisition announces monthly extension to complete business combination - Bannix Acquisition announced that its board of directors has decided to extend the date by which Bannix must consummate an initial business combination from March 14, 2023 for an additional month, to April 14, 2023. As previously disclosed, at a special meeting of its stockholders held on March 8, 2023, Bannix's stockholders voted in favor of a proposal to amend Bannix's Amended and Restated Certificate of Incorporation to provide Bannix with the right to extend the Deadline Date up to 12 times for an additional one month each time, from March 14, 2023 to up to March 14, 2024. On March 9, 2023, Bannix filed the Amended Charter with the Secretary of State of the State of Delaware.Also as previously announced, if an Extension is implemented, the sponsor of Bannix, Instant Fame, or its designees will deposit into the trust account, as a loan, the lesser of $75,000 and $0.07 for each share that is not redeemed in connection with the special meeting. In connection with the initial Extension, on March 13, 2023, Bannix issued an unsecured promissory note to the Sponsor with a principal amount equal to $75,000. The Note bears no interest and is repayable in full upon the earlier of the date of the consummation of Bannix's initial business combination, or the date of the liquidation of Bannix. If Bannix does not consummate an initial business combination by the Deadline Date, the Note will be repaid only from funds held outside of the trust account or will be forfeited, eliminated or otherwise forgiven. On March 13, 2023, the Board, at the request of the Sponsor, decided to implement a first Extension and to extend the Deadline Date for an additional month to March 14, 2023.

07:15 EDT Atea announces presentation of Phase 1 data of bemnifosbuvir at ICAR 2023 - Atea Pharmaceuticals announced the presentation of new Phase 1, in vitro and in vivo data that demonstrate key profile attributes of Atea's lead drug candidate, bemnifosbuvir, for the treatment of COVID-19 and hepatitis C. Additionally, new data for AT-752 for dengue and a nucleotide analogue are being presented. These results are being presented at the 36th International Conference on Antiviral Research, ICAR 2023, taking place March 13-17, 2023 in Lyon, France. Key highlights of the presentations include results from a Phase 1 human absorption, distribution, metabolism, and excretion, ADME, study for bemnifosbuvir demonstrating a favorable ADME profile supportive of the dosing regimen used in SUNRISE-3, a global, multicenter Phase 3 registrational trial for the treatment of COVID-19. In vitro metabolism and transporter interaction studies showed bemnifosbuvir has a low risk for interactions with medicines commonly prescribed to patients at risk for COVID-19 progression and for those with HCV infection. In vitro studies also demonstrated advantages of bemnifosbuvir's mechanism of action, which targets conserved regions of the viruses that cause COVID-19 and HCV infection. Additionally, the combination of bemnifosbuvir and ruzasvir for the treatment of HCV demonstrated potent in vitro synergistic antiviral activity and in vivo preclinical safety without adverse interactions. "As we continue to advance late-stage development of bemnifosbuvir, these data demonstrate that our lead compound has the potential to improve the current standard of care and address key unmet needs and limitations for patients with COVID-19 and HCV," said Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals. "These data support a favorable safety and drug interaction profile of bemnifosbuvir to treat these conditions and to provide vulnerable patients with another therapeutic option."

07:11 EDT Autolus Therapeutics CFO Lucinda Crabtree to step down - Autolus Therapeutics announced that Dr. Lucinda Crabtree has provided notice of her resignation as CFO of the Company to pursue a new opportunity. Dr Crabtree will remain with the Company until Q3, 2023 in order to ensure a smooth and orderly transition. Autolus has initiated a formal search process for the selection of a new CFO.

07:09 EDT Core Molding sees 2023 capex $13M - The Company's capital expenditures for 2022 were $16.6 million, including $8.8 million of capacity expansion and automation investments. The Company plans for 2023 capital expenditures of approximately $13 million to meet current demand and allow us to add new business.

07:06 EDT CGI Inc. unit awarded $40M contract from U.S. Nuclear Regulatory Commission - CGI Federal, the wholly-owned U.S. operating subsidiary of CGI Inc., announced that it has been awarded a 5-year, indefinite-delivery, indefinite quantity contract with a total contract value of up to $40M with the U.S. Nuclear Regulatory Commission. Under this new contract vehicle, CGI Federal will provide ongoing support for NRC financial management systems, which use CGI Federal's Momentum federal enterprise resource planning solution at their core.

07:06 EDT Broadridge signs strategic technology integration agreement with CQG - Broadridge Financial Solutions announced a strategic partnership with CQG, a global provider of technology solutions for market makers, traders, brokers, commercial hedgers and exchanges, that will integrate the two firms' Execution Management System - EMS - and Order Management System - OMS - respectively. The combination of CQG's front-end trading technology with Broadridge's Order Management System and the NYFIX network will be a first of its kind out-of-the-box solution for a full front-, middle- and back-office technology suite. CQG completed a FIX connection into Broadridge to allow for order flow from CQG directly into Broadridge's infrastructure to be managed and routed out to its network of exchanges and liquidity providers. Additional development underway will complete the effort to allow for workflow between the two systems. Viewing and managing orders will be achievable and in-sync in either system.

07:03 EDT Honeywell says Vimal Kapur to succeed Darius Adamczyk as CEO on June 1 - Honeywell announced that Vimal Kapur, President and COO, will succeed Darius Adamczyk as CEO on June 1. Adamczyk, who became COO in 2016, CEO in 2017 and Chairman in 2018, will continue to serve as Executive Chairman of Honeywell. Kapur was also appointed to the company's board of directors effective March 13. These moves ensure a seamless leadership transition and position Honeywell for continued outperformance versus peers. Kapur was named President and COO in July of 2022, and has been leading the creation of new solutions to help customers drive their sustainability transformations and accelerate their digital transformation journeys. Prior to his role as COO, Vimal served as President and CEO of PMT.

07:01 EDT Honeywell says Vimal Kapur to succeed Darius Adamczyk as CEO on June 1

06:58 EDT Hancock Whitney: Previous PPNR guidance of 13%-18% y/y 'under pressure' - In an update on deposit trends, liquidity and capital on Monday, Hancock Whitney said its previous PPNR guidance of 13%-18% over 2022 levels is "under pressure" and will be re-evaluated on the Q1 earnings call. Hanock Whitney said it remains in a "solid" capital position, with the February 28 CET1 ratio estimated at 11.59%, up 18bps from year-end 2022. Its TCE ratio was 7.17% at February 28, up 8bps compared to year-end 2022.

06:53 EDT NovaBay to sell Eyeganics' Organic Tears - NovaBay announces a partnership with Eyeganics to sell OTC Organic Tears on Avenova.com and through Avenova's physician-dispensed channel. Organic Tears has no additives or artificial chemicals and is the only lubricant eye drop certified by the USDA as 100% organic and preservative-free.

06:50 EDT Southwest announces actions to boost operations - Southwest will share an overview of the prioritized actions being implemented in an effort to strengthen the airline's operational resiliency. The actions will be previewed by Bob Jordan, Southwest's president and CEO, at the J.P. Morgan Industrials Conference in New York. As a result of the initial assessments conducted by Southwest, the airline has developed a three-part tactical action plan to boost operational resiliency in key areas across the company. The airline's existing five-year operational modernization plan, which began in 2022, is also underway and focuses on operational investments and organizational alignment to support customers and employees. In addition to Winter Storm Elliot, which was more severe than expected, a driver of the disruption was determined to be the volume of cascading and close-in flight cancelations during the storm which overwhelmed Station operations and the airline's crew network and hindered established processes and internal tools. While the airline had existing technology and staffing in place to handle many types of irregular operations, the pace and breadth of disruptions during this extreme event strained the ability to create timely operational solutions. The airline will provide additional communication in the coming weeks, including a microsite summarizing key findings and mitigation actions. The airline began a five-year operational modernization plan prior to December 2022 with many initiatives already underway to support operational resiliency. Now, ongoing implementation of tools and technology that allow for a greater pace of recovery during extreme events will be prioritized, and the airline is, currently, budgeted to spend more than $1.3B on investments, upgrades, and maintenance of information technology systems in 2023. For example, Crew Optimization software has been recently upgraded to address a functional gap that was revealed in December. Crew Scheduling and Customer phone systems also will be upgraded for better surge protection and efficiency during periods of high call volumes. Challenges with infrastructure, winter equipment, and winter weather preparedness have been, or will be, addressed through various actions, including purchasing additional deicing trucks; securing additional deicing pads and deicing fluid capacity at key network locations; and purchasing more engine covers and engine heaters for cold weather operations. Southwest was the first U.S. airline to hire back to pre-pandemic total staffing by June 2022, and, going forward, the airline will further augment winter staffing levels-for example, when Ground Operations Employees are limited to the amount of time they can work outside in extreme temperatures. Additionally, the airline plans to implement a new weather application to provide Crews with more real-time and dynamic weather indications to enhance deicing holdover times-which determines the time required before aircraft must be deiced again prior to departure. Actions have already been taken to align various Network Planning and Network Operations Control Teams under one Senior Leader. Additionally, data on early-indicator dashboards has been enhanced to highlight key operational metrics, and the airline will better integrate aircraft and Crew recovery decision making and optimization.

06:38 EDT Southwest sees negative revenue impact of $300M-$350M in Q1 - The company continues to estimate a negative revenue impact in the range of $300 million to $350 million in first quarter 2023, primarily isolated to January and February, associated with the December 2022 operational disruptions. However, the Company also continues to experience strong revenue trends in March 2023, primarily driven by strong yields and notable strength in Rapid Rewards redemptions. Additionally, the Company continues to expect March 2023 managed business revenues to be roughly restored to March 2019 levels. Looking ahead, and based on current trends, bookings for second quarter 2023 appear solid and in line with expectations.

06:37 EDT Southwest sees FY23 ASMs up 15%-16% y/y vs. prior 16%-17% view - Sees FY23 CASM-X down 3.5%-5.5% y/y vs. prior view of down 6%-8%.

06:33 EDT Volkswagen: BEV deliveries rose 26% in 2022 - Volkswagen said: "Although overall delivery numbers declined 7 percent to 8.3 million vehicles in 2022, Volkswagen Group remains well-positioned for future growth. Operating margins before special items grew to 8.1 percent in 2022, reflecting the Group's continued pricing discipline and cost progress and was driven by a stronger model mix. The automotive division's net cash flow decreased to EUR 4.8 billion. This was caused by an increase in working capital due to supply chain and logistics issues, especially towards the end of the year. In the course of 2023, this effect should largely reverse and strengthen the automotive division's net liquidity. With a high order book of 1.8 million vehicles and a unique product portfolio, the Group maintains a strong position and expects supply chain bottlenecks should gradually ease in 2023." BEVs now account for 16 percent of the Group's order book, the company said.

06:31 EDT BJ's Wholesale announces partnership with Simbe - BJ's Wholesale Club announced its partnership with Simbe to roll out the company's business intelligence solution, Tally, to all club locations across the company's footprint. Incorporating Simbe's AI-powered solution into chainwide operations will provide greater visibility into club conditions and deeper business insights, ultimately improving operational efficiencies and enhancing the member experience.

06:01 EDT ZoomInfo announces $100M share repurchase program - ZoomInfo announced that its Board of Directors approved a share repurchase program authorizing the company to repurchase, from time to time, up to $100M of the company's common stock.

05:58 EDT Credit Suisse finds 'material weaknesses' in financial reporting controls - In its annual report on Tuesday, Credit Suisse said it had identified "material weaknesses" in its internal controls over financial reporting. Credit Suisse said "management did not design and maintain an effective risk assessment process to identify and analyze the risk of material misstatements in its financial statements." "Notwithstanding these material weaknesses, we confirm that our consolidated financial statements as included in this Annual Report fairly present, in all material respects, our consolidated financial condition as of December 31, 2022 and 2021, and our consolidated results of operations and cash flows for the years ended December 31, 2022, 2021 and 2020, in conformity with US GAAP. "

05:19 EDT Arrow Electronics, Qualcomm expand their collaboration - Arrow Electronics (ARW) and Qualcomm (QCOM) have expanded their strategic collaboration. The establishment of Edge Labs, an Arrow Center of Excellence, or CoE, will help customers accelerate the development of connected intelligent edge devices based on solutions from Qualcomm Technologies. Edge and AI solution development is becoming increasingly challenging to customers due to several factors such as lack of prior experience, limited access to high-performance edge and AI chipsets, supply chain complexity and fledgling ecosystem. Edge Labs aims to help innovators navigate these challenges while increasing the adoption of Edge AI using solutions from Qualcomm Technologies across security, safety, healthcare, robotics, cameras, displays, optical inspection and other IoT applications. Edge Labs will have a dedicated solution architect and engineering team to develop application-specific solutions, including training sales and field application engineers specifically on Qualcomm Technologies' products. It will also offer design services to enable lower risk and faster time to market for customers through eInfochips, an Arrow company.

05:13 EDT Fortuna Silver Mines obtains permanent injunction for San Jose mine - Fortuna Silver Mines reported that the Mexican Federal Administrative Court has granted a permanent injunction to Compania Minera Cuzcatlan, Fortuna's Mexican subsidiary, which allows the San Jose Mine to continue to operate under the terms of the 12-year environmental impact authorization, or EIA.